Injectable and sublingual formulations are listed for consultation. FDA-approved GLP-1 products have specific indications; compounded and sublingual preparations are not equivalent to an FDA-approved product and require individualized medical justification where legally available.
Semaglutide Sublingual Microdose
Semaglutide Sublingual
Semaglutide Injectable Microdose with B12
Semaglutide Injectable Microdose with Glycine
Semaglutide Injectable with B12
Semaglutide Injectable with Glycine
Tirzepatide Sublingual Microdose
Tirzepatide Sublingual
Tirzepatide Injectable Microdose with B12
Tirzepatide Injectable Microdose with Glycine
Tirzepatide Injectable with B12
Tirzepatide Injectable with Glycine
GLP-1 therapy is not appropriate for everyone. The clinician reviews contraindications, interactions, pregnancy plans, personal and family history, side effects, and the regulatory status of the specific product before prescribing.